Literature DB >> 33042572

Correction to: Assessing the acceptability of a text messaging service and smartphone app to support patient adherence to medications prescribed for high blood pressure: a pilot study.

Aikaterini Kassavou1, Charlotte Emily A'Court1,2, Jagmohan Chauhan3, James David Brimicombe1, Debi Bhattacharya4, Felix Naughton5, Wendy Hardeman5, Cecilia Mascolo3, Stephen Sutton1.   

Abstract

[This corrects the article DOI: 10.1186/s40814-020-00666-2.].
© The Author(s) 2020.

Entities:  

Year:  2020        PMID： 33042572      PMCID： PMC7541290          DOI： 10.1186/s40814-020-00698-8

Source DB:  PubMed          Journal:  Pilot Feasibility Stud        ISSN： 2055-5784


Correction to: Pilot Feasibility Stud 6, 134 (2020) https://doi.org/10.1186/s40814-020-00666-2 Following publication of the original article [1], the authors reported an error in the name of the fourth author. The surname should be Brimicombe. The original article has been updated.
  1 in total

1.  Assessing the acceptability of a text messaging service and smartphone app to support patient adherence to medications prescribed for high blood pressure: a pilot study.

Authors:  Aikaterini Kassavou; Charlotte Emily A'Court; Jagmohan Chauhan; James David Brimocombe; Debi Bhattacharya; Felix Naughton; Wendy Hardeman; Cecilia Mascolo; Stephen Sutton
Journal:  Pilot Feasibility Stud       Date:  2020-09-21
  1 in total
  1 in total

1.  The feasibility of the PAM intervention to support treatment-adherence in people with hypertension in primary care: a randomised clinical controlled trial.

Authors:  Aikaterini Kassavou; Venus Mirzaei; Sonia Shpendi; James Brimicombe; Jagmohan Chauhan; Debi Bhattacharya; Felix Naughton; Wendy Hardeman; Helen Eborall; Miranda Van Emmenis; Anna De Simoni; Amrit Takhar; Pankaj Gupta; Prashanth Patel; Cecilia Mascolo; Andrew Toby Prevost; Stephen Morris; Simon Griffin; Richard J McManus; Jonathan Mant; Stephen Sutton
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.